Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · Real-Time Price · USD
131.91
+0.10 (0.07%)
Mar 31, 2025, 10:13 AM EDT - Market open
Intra-Cellular Therapies Market Cap
Intra-Cellular Therapies has a market cap or net worth of $14.03 billion as of March 31, 2025. Its market cap has increased by 122.17% in one year.
Market Cap
14.03B
Enterprise Value
13.03B
1-Year Change
122.17%
Ranking
Category
Stock Price
$131.91
Market Cap Chart
Since January 7, 2014, Intra-Cellular Therapies's market cap has increased from $332.00M to $14.03B, an increase of 4,124.45%. That is a compound annual growth rate of 39.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 14.02B | 58.28% |
| Dec 31, 2024 | 8.85B | 28.46% |
| Dec 29, 2023 | 6.89B | 37.53% |
| Dec 30, 2022 | 5.01B | 17.54% |
| Dec 31, 2021 | 4.26B | 67.27% |
| Dec 31, 2020 | 2.55B | 34.44% |
| Dec 31, 2019 | 1.90B | 204.19% |
| Dec 31, 2018 | 623.30M | -21.13% |
| Dec 29, 2017 | 790.30M | 21.04% |
| Dec 30, 2016 | 652.90M | -71.79% |
| Dec 31, 2015 | 2.31B | 345.98% |
| Dec 31, 2014 | 518.90M | 56.30% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |